Search

Your search keyword '"Hata, Taishi"' showing total 867 results

Search Constraints

Start Over You searched for: Author "Hata, Taishi" Remove constraint Author: "Hata, Taishi"
867 results on '"Hata, Taishi"'

Search Results

2. Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer

3. Development of novel rectal/uterine clamping device

6. Influence of the rotation of the diverting loop ileostomy in rectal cancer surgery on small-bowel obstruction: A multicenter prospective study conducted by the Clinical Study Group of Osaka University, Colorectal Group

7. Phase II dose titration study of regorafenib in progressive unresectable metastatic colorectal cancer

9. Safety and feasibility of minimally invasive distal pancreatectomy for pancreatic cancer in elderly patients: A retrospective study.

11. Phase II study of 5-fluorouracil–leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802)

19. Minimally invasive liver resection for cholangiolocellular carcinoma: A single‐institution experience

20. The Supercarbonate Apatite-MicroRNA Complex Inhibits Dextran Sodium Sulfate-Induced Colitis

24. Benefits of using a self-expandable metallic stent as a bridge to surgery for right- and left-sided obstructive colorectal cancers

25. Preventive effect of a traditional Japanese Kampo medicine, shakuyakukanzoto, against neurotoxicity of FOLFOX plus bevacizumab used for metastatic colorectal cancer management: A single‐arm phase II study

26. Usefulness of blood flow evaluation by indocyanine green fluorescence in laparoscopic or robot‐assisted surgery for colorectal cancer with persistent descending mesocolon

27. Minimally invasive liver resection for cholangiolocellular carcinoma: A single‐institution experience.

30. Fig. S6 from A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS-Mutant Colon Cancer Cells

31. Data from A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS-Mutant Colon Cancer Cells

32. Table S1 from A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS-Mutant Colon Cancer Cells

33. Fig. S3 from Photodynamic Therapy Using Indocyanine Green Loaded on Super Carbonate Apatite as Minimally Invasive Cancer Treatment

34. Effects of Goshajinkigan (TJ-107) for oxaliplatin-induced peripheral neurotoxicity using the functional assessment of cancer therapy/gynecologic oncology group 12-item neurotoxicity questionnaire in a Phase II, multicenter, randomized, double-blind, placebo-controlled trial

36. Data from Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells

37. Supplementary methods from Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells

38. The proteasome activities of LPACs and non-LPACs. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

39. Supplementary legend from Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells

40. Supplementary Figure. S3 from Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells

41. The list of universally elevated genes in LPACs of all cell lines using microarray analysis. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

42. Analysis of LPACs and non-LPACs based on various stem cell markers. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

43. The confirmation of stable ZsGreen expression in CRC cell lines. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

44. The validation of over-expression of EID3 and down- regulation of EID3. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

45. Relationship between EID3 expression and clinicopathological factors in patients with colorectal cancer from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

46. Supplementary Table from Disruption of Endolysosomal RAB5/7 Efficiently Eliminates Colorectal Cancer Stem Cells

47. LPACs were not detected transitioning from non-LPACs. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

48. Validation of EID3 expression in LPACs. from Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity

Catalog

Books, media, physical & digital resources